| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/03/2006 | CN1254469C Arylsulfonyl derivatives with 5-HT6 receptor affinity |
| 05/03/2006 | CN1254270C Water-soluble ginger-root extract |
| 05/03/2006 | CN1254239C Animal model of schizophrenia and its medicine sorting platform |
| 05/02/2006 | USRE39088 Amide compounds and use of the same |
| 05/02/2006 | US7038055 Sulfone derivatives and their use in the treatment of autoimmune diseases and allergies |
| 05/02/2006 | US7038051 Imidazonaphthyridines |
| 05/02/2006 | US7038048 Compositions for treatment of cell proliferation disorders |
| 05/02/2006 | US7038035 Nucleic acids codes polypeptides; mutants; insertion a vector; culturing; recovering |
| 05/02/2006 | US7038029 Vaccination |
| 05/02/2006 | US7038028 Gene encoding promoter domain of tumor suppressor gene P51 and use thereof |
| 05/02/2006 | US7038016 Dissolving a stable, activated polyoxyethylene glycol (carboxymethyloxy-end group)(aPEG) in a solvent; filtering the the solution to reduce the bioburden/endotoxin levels; used for the preparation of a PEGylated hemoglobin solution |
| 05/02/2006 | US7038012 Enrichment process for H. pylori neutrophil activating protein (NAP) utilizing metal chelate chromatography |
| 05/02/2006 | US7037940 Taxol enhancer compounds |
| 05/02/2006 | US7037938 For therapy of urinary incontinence |
| 05/02/2006 | US7037929 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 05/02/2006 | US7037926 Anticarcinogenic, antiallergen, and antiinflammatory agents; autoimmuned diseases |
| 05/02/2006 | US7037925 for treating or preventing organ transplant rejection, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, Type I diabetes, asthma, rhinitis, atopic dermatitis, autoimmune disorders, Alzheimer's disease, leukemia |
| 05/02/2006 | US7037921 Compounds and methods for inhibiting MRP1 |
| 05/02/2006 | US7037920 Substituted tricyclic himbacine derivatives that are useful as thrombin receptor antagonists |
| 05/02/2006 | US7037919 novel nonsteroidal compounds and salts; have a specific and strong binding affinity for androgen receptors and exhibit AR agonism or antagonism; therapeutic effect on AR-mediated diseases such as male hypogonadism, male sexual dysfunction, anemia, aids, breast, prostate cancer |
| 05/02/2006 | US7037918 Antidiabetic agents, cardiovascular disorders, Alzheimer's disease, nervous system disorders |
| 05/02/2006 | US7037907 Prodrug of an estradiol conjugated to a glucuronide sugar; 6-oxo-2-methoxyestradiol; 3-acetyl-6-oxo-2-methoxyestradiol; and 2-methoxyestradiol-6-hydrazone; angiogenesis inhibitor; antiinflammatory for asthma or rheumatoid arthritis |
| 05/02/2006 | US7037896 HIV inhibiting peptide (VIRIP) and amidated, acetylated, sulfated, polyethylene glycol modified, phosphorylated and/or glycosylated derivatives |
| 05/02/2006 | US7037719 Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations |
| 05/02/2006 | US7037718 Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof |
| 05/02/2006 | US7037702 Hydrolase polypeptide for dephosphorylating mitogen activated kinases (MAP-kinase); antiapoptosis; antiproliferative agents |
| 05/02/2006 | US7037701 Genetic engineering; detection moderators of kinase peptidespeptides |
| 05/02/2006 | US7037685 Nucleotide sequence coding polypeptide for use in the treatment and prevent of viral diseases, infections and tumors |
| 05/02/2006 | US7037666 Contacting latency-associated peptide- beta 1 (LAP- beta 1) or a functional variant thereof and integrin alpha v beta 3 or a functional variant thereof with test product under conditions that, in absence of test product, would permit interaction |
| 05/02/2006 | US7037665 Compositions comprising SNORF36 receptor compounds |
| 05/02/2006 | US7037647 Prostate-specific membrane antigen and uses thereof |
| 05/02/2006 | US7037536 α-amylase activity inhibitors |
| 05/02/2006 | US7037504 Resistant to proteolysis, and gene sequences encoding these forms and having codons optimized for usage by an industrial production organism, are provided. |
| 05/02/2006 | US7037495 Antimicrobial compositions |
| 05/02/2006 | US7037489 Skin external agents and drugs |
| 05/02/2006 | CA2358394C Tricyclic amides useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 05/02/2006 | CA2326804C Compounds with activity on muscarinic receptors |
| 05/02/2006 | CA2250426C Amidinohydrazones as protease inhibitors |
| 05/02/2006 | CA2184375C Oligonucleotide n3'-p5' phosphoramidates: synthesis and compounds; hybridization and nuclease resistance properties |
| 05/02/2006 | CA2174544C Method for using pharmaceutical compositions containing 2-(2-alkylphenylamino)-oxazolines, 2-(2-alkylphenyl-amino)-thiazolines and 2-(2-alkylphenylamino)-imidazolines as adrenergic agents |
| 05/02/2006 | CA2061836C Nmda antagonists |
| 04/27/2006 | WO2006044582A2 Use of baff to treat sepsis |
| 04/27/2006 | WO2006044379A2 Novel curcumin analogues and uses thereof |
| 04/27/2006 | WO2006043728A1 Method of screening insulin resistance-improving agent |
| 04/27/2006 | WO2006043701A1 Method of inhibiting phosphorylation of transcriptional factor for gluconeogenesis-associated gene and phosphorylation inhibitor |
| 04/27/2006 | WO2006043671A1 TRANSCRIPTIONAL FACTOR Nrf2 ACTIVATOR AND FOOD HAVING THE FUNCTION OF THE SAME IMPARTED THERETO |
| 04/27/2006 | WO2006043655A1 Medicinal composition for inhalation |
| 04/27/2006 | WO2006043594A1 1,5-diheterocycle-1h-triazole derivative |
| 04/27/2006 | WO2006043532A1 Therapeutic agent for parkinson's disease |
| 04/27/2006 | WO2006043518A1 Drug for treating neurological disease |
| 04/27/2006 | WO2006043477A1 Nerve growth factor production inhibitor and external preparation for the skin, cosmetic, quasi drug, preventive and remedy for itching and remedy for atopic dermatitis containing the nerve growth factor production inhibitor |
| 04/27/2006 | WO2006010009A3 Hyaluronic acid in the enhancement of lens regeneration |
| 04/27/2006 | WO2006002453A3 Use of a deubiquitinating compound for enhancing the expression of membrane proteins on the cell surface |
| 04/27/2006 | WO2005027903A8 Polyether brevetoxin derivatives as a treatment for neurotoxic shellfish poisoning and ciguatera fish poisoning |
| 04/27/2006 | WO2003040333A3 Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and for enhancing survival of neurons and uses thereof |
| 04/27/2006 | US20060089498 3-amino-2-ethoxycarbonylpyrrole; chemical intermediate in synthesis of 3H,5H-pyrrolo[3,2-d]pyrimidin-4-one; a convergent synthesis route rather than a linear one |
| 04/27/2006 | US20060089401 Kinase inhibitors |
| 04/27/2006 | US20060089395 Nf-kb activation inhibitors |
| 04/27/2006 | US20060089394 {[2-Methyl-4-({[4'-(trifluoromethyl)-3-biphenylyl]methyl}thio)phenyl]oxy}acetic acid; adipogenic signalling cascade and lipid homeostasis; increase High Density Lipoproteins; hypotensive agent; Syndrome X, obesity, insulin resistance, cardiovascular disorder |
| 04/27/2006 | US20060089393 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 04/27/2006 | US20060089379 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity |
| 04/27/2006 | US20060089368 Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
| 04/27/2006 | US20060089366 New piperazine and piperidine compounds |
| 04/27/2006 | US20060089362 N-(2- piperazinophenyl) methyl 3-(3-chlorophenyl)-pyrazolo-[1,5-a]-pyrimidine-6-amide; treats circulatory diseases such as diseases due to inflammation, circulatory disorders, enhanced proliferation activities, and the like, i.e., hypertension, diabetes, diabetic complications, arteriosclerosis |
| 04/27/2006 | US20060089353 Indole derivative compounds and drugs containing the compounds as the active ingredient |
| 04/27/2006 | US20060089345 Indole derivatives, method for preparating same and pharmaceutical compositions containing same |
| 04/27/2006 | US20060089336 4-Dedimethylamino tetracycline compounds |
| 04/27/2006 | US20060089334 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 04/27/2006 | US20060089327 Combinations comprising epothilones and anti-metabolites |
| 04/27/2006 | US20060089326 Immunostimulatory nucleic acid molecules |
| 04/27/2006 | US20060089320 Modulation of type IIß phosphoinositide phosphate kinase |
| 04/27/2006 | US20060089312 Protease inhibitors |
| 04/27/2006 | US20060089299 Selective treatment of endothelial somatostatin receptors |
| 04/27/2006 | US20060088932 Truncated glycogen synthase kinase 3 crystallizable polypeptide; drug screening for Alzheimer's Disease treatments, antidiabetic and antiinflammatory agents |
| 04/27/2006 | US20060088913 Mutation associated with epilepsy |
| 04/27/2006 | US20060088908 Mutiens of human neutrophil gelatinase-associated lipocalin and related proteins |
| 04/27/2006 | US20060088890 Identification and isolation of somatic stem cells and uses thereof |
| 04/27/2006 | US20060088881 Methods and compositions for treating urological disorders using 1435, 559, 34021, 44099, 25278, 641, 260, 55089, 21407, 42032, 46656, 62553, 302, 323, 12303, 985, 13237, 13601, 18926, 318, 2058 or 6351 molecules |
| 04/27/2006 | US20060088824 Used in assays to identify PAP-1/WIP-1 interaction inhibitors; West Nile virus (WNV) |
| 04/27/2006 | US20060088598 Intravenous composition, process for producing the same and preparation thereof |
| 04/27/2006 | US20060088595 Dispersant for sustained release preparations |
| 04/27/2006 | US20060088552 Method for inhibiting cell death, cell death inhibitor, and remedy for disease caused by cell death containing the cell death inhibitor |
| 04/27/2006 | US20060088540 Antagonists and methods for inhibiting angiogenesis |
| 04/27/2006 | US20060088535 Method for enhancing long-term memory in a subject and uses thereof |
| 04/27/2006 | US20060088529 Bispecific monoclonal antibodies to IL-12 and IL-18 |
| 04/27/2006 | US20060088521 Composition and method for cancer treatment |
| 04/27/2006 | US20060088513 Antiallergic composition |
| 04/27/2006 | US20060088505 Hair follicle mesenchymal stem cells and use thereof |
| 04/27/2006 | US20060088502 Drug for reducing side effects in ribavirin interferon combination therapy |
| 04/27/2006 | US20060088485 Piperonyl alcohol; storage stability |
| 04/27/2006 | CA2583943A1 Novel curcumin analogues and uses thereof |
| 04/27/2006 | CA2583900A1 Use of baff to treat sepsis |
| 04/27/2006 | CA2583153A1 1,5-diheterocycle-1h-triazole derivative |
| 04/26/2006 | EP1650307A2 Methods for making recombinant proteins using apoptosis inhibitors |
| 04/26/2006 | EP1650203A1 Process of preparation of benzimidazol-2-yl quinolinone derivatives |
| 04/26/2006 | EP1650201A1 Benzoxazepine compound |
| 04/26/2006 | EP1650199A1 Sulfonamide derivative having isoxazole ring |
| 04/26/2006 | EP1650195A1 Method of inhibiting production of osteopontin |
| 04/26/2006 | EP1650194A1 Protein kinase inhibitor |
| 04/26/2006 | EP1650191A1 Therapeutic agent for chronic obstructive pulmonary disease and method of treatment for chronic obstructive pulmonary disease with the same |